Ultragenyx Pharmaceutical
RARE
RARE
176 hedge funds and large institutions have $3.8B invested in Ultragenyx Pharmaceutical in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 59 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% more capital invested
Capital invested by funds: $3.75B → $3.8B (+$48.1M)
22% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 59
Holders
176
Holding in Top 10
1
Calls
$40.4M
Puts
$6.55M
Top Buyers
| 1 | +$57.6M | |
| 2 | +$48.1M | |
| 3 | +$21.8M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.9M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$20M |
Top Sellers
| 1 | -$62.2M | |
| 2 | -$21.6M | |
| 3 | -$21M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$17.6M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$13.5M |